These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6112449)

  • 21. Twenty-three-year follow-up study of rubella antibodies after immunization in a closed population, and serological response to revaccination.
    Asahi T; Ueda K; Hidaka Y; Miyazaki C; Tanaka Y; Nishima S
    Vaccine; 1997 Nov; 15(16):1791-5. PubMed ID: 9364685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rubella vaccination in Australia: 2. Experience with the RA27/3 rubella vaccine and results of a double-blind trial in schoolgirls.
    Menser MA; Forrest JM; Bransby RD; Collins E
    Med J Aust; 1978 Jul; 2(3):85-8. PubMed ID: 362141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the reactogenicity and immunogenicity of the BRD-2 and RA27/3 live attenuated rubella vaccines.
    Wang SS; Han YR; Su WN; Chen J; Zhao K
    Vaccine; 1984 Dec; 2(4):277-80. PubMed ID: 6531968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistence of antibody titers after vaccination with rubella virus vaccine ("Cendehill" strain).
    Peetermans J; du Pan RM; Huygelen C
    Dev Biol Stand; 1979; 43():361-5. PubMed ID: 520683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Wistar RA27/3 rubella virus vaccine in children.
    Balfour HH; Balfour CL; Edelman CK; Rierson PA
    Am J Dis Child; 1976 Oct; 130(10):1089-91. PubMed ID: 973611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Rubella vaccination: antibody persistence for 14-17 years and immune status of women without and with a history of vaccination].
    Enders G; Nickerl U
    Immun Infekt; 1988 Apr; 16(2):58-64. PubMed ID: 3391631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of low level immunity on response to live rubella virus vaccine.
    Väänänen P; Mäkelä P; Vaheri A
    Vaccine; 1986 Mar; 4(1):5-8. PubMed ID: 3962450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific immunoglobulin responses in serum and nasal secretions after the administration of attenuated rubella vaccine.
    Cradock-Watson JE; Macdonald H; Ridehalgh MK; Bourne MS; Vandervelde EM
    J Hyg (Lond); 1974 Aug; 73(1):127-41. PubMed ID: 4608331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late seroconversion following HPV-77, DE5 rubella virus vaccine.
    Wilkins J
    Am J Obstet Gynecol; 1975 Apr; 121(7):998-1002. PubMed ID: 1115189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of immunoglobulin M-antibodies after rubella immunization with RA27/3 attenuated live vaccine in teen-agers: remaining problems.
    Braito A; Fanti O; Rossolini GM; Cellesi C
    Boll Ist Sieroter Milan; 1991-1992; 70(1-2):443-8. PubMed ID: 1670047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rubella screening and immunisation of schoolgirls: results six to seven years after vaccination.
    Zealley H; Edmond E
    Br Med J (Clin Res Ed); 1982 Feb; 284(6313):382-4. PubMed ID: 6800467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of methods for detecting specific IgM antibody in infants with congenital rubella.
    Pattison JR; Jackson CM; Hiscock JA; Cradock-Watson JE; Ridehalgh MK
    J Med Microbiol; 1978 Nov; 11(4):411-8. PubMed ID: 364063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Demonstration of Rubella-specific IgG and IgM antibody (sub) classes using the enzyme immunoassay (EIA)].
    Doerr HW; Fleischer G; Wiesmann M
    Immun Infekt; 1984 Feb; 12(1):21-8. PubMed ID: 6398271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged rubella IgM antibody response.
    Stallman ND; Allan BC; Sutherland CJ
    Med J Aust; 1974 Oct; 2(17):629-31. PubMed ID: 4444610
    [No Abstract]   [Full Text] [Related]  

  • 35. Susceptibility to rubella and borderline immunity.
    Fogel A; Barnea B; Gerichter CB
    Isr J Med Sci; 1983 Oct; 19(10):934-5. PubMed ID: 6363349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rubella antibody titres and immunization status in a family practice.
    Mills DA; Parker KR; Evans CE
    Can Med Assoc J; 1980 Mar; 122(5):549-52. PubMed ID: 7370858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody titres in women six to eight years after the administration of RA2713 and Cendehill rubella vaccines.
    Macdonald H; Tobin JO; Cradock-Watson JE; Lomax J
    J Hyg (Lond); 1978 Jun; 80(3):337-47. PubMed ID: 649946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of immunization against rubella on lactation products. I. Development and characterization of specific immunologic reactivity in breast milk.
    Losonsky GA; Fishaut JM; Strussenberg J; Ogra PL
    J Infect Dis; 1982 May; 145(5):654-60. PubMed ID: 7077089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of a vaccination programme on the distribution of rubella antibodies in women of childbearing age.
    Hambling MH
    Lancet; 1975 May; 1(7916):1130-3. PubMed ID: 49484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on rubella vaccination in adult females. I: Clinical and laboratory studies on clinical reactions].
    Nakazono N
    Hokkaido Igaku Zasshi; 1984 Mar; 59(2):180-91. PubMed ID: 6745839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.